Literature DB >> 8147613

Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus.

M Baba1, T Aikou, H Yoshinaka, S Natsugoe, T Fukumoto, H Shimazu, K Akazawa.   

Abstract

OBJECTIVE: This study evaluated the impact of aggressive surgery on survival in patients with carcinoma of the thoracic esophagus. SUMMARY BACKGROUND DATA: Prognostic value of lymph-node status for patients with esophageal carcinoma was emphasized, although it is currently under debate whether extensive lymph node dissection improves survival.
METHODS: Two hundred ninety-five patients with thoracic esophageal carcinoma were admitted to Kagoshima University Hospital from December 1982 to December 1990. Esophagectomy was performed on 244 (82.7%) of these patients; 106 of whom underwent three-field lymphadenectomy (bilateral cervical, mediastinal, and abdominal regions) were analyzed regarding lymph-node status, tumor recurrence, and the effect of prognostic factors on survival using Cox's proportional hazards model.
RESULTS: Hospital mortality and morbidity were 10.4% (11/106) and 65.1%, respectively. Seventy-eight patients (73.6%) had nodal involvement, including 49 patients with abdominal lymph-node metastases and 46 patients with recurrent nerve-node metastases. Five-year survival rates were 54.5% for 16 patients with a solitary nodal metastasis, 30.3% for stage III, 17.4% for stage IV, and 7.2% for 28 patients with six or more metastatic nodes. The most frequent sites of recurrence were the upper mediastinal region and the lung--its incidence increased significantly as the number of positive nodes increased. The most unfavorable prognostic factors included regional or recurrent nerve-node metastasis and patient age of more than 71 years.
CONCLUSIONS: Three-field lymphadenectomy, including especially the removal of bilateral recurrent nerve nodes in the cervical region, is essential for improving the survival of patients with carcinoma of the upper two thirds of the thoracic esophagus.

Entities:  

Mesh:

Year:  1994        PMID: 8147613      PMCID: PMC1243140          DOI: 10.1097/00000658-199403000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  16 in total

1.  [Clinical evaluation of the esophageal lymph flow system based on RI uptake of dissected regional lymph nodes following lymphoscintigraphy].

Authors:  G Tanabe; M Baba; K Kuroshima; S Natugoe; H Yoshinaka; T Aikou; T Kajisa
Journal:  Nihon Geka Gakkai Zasshi       Date:  1986-03

2.  Gross and microscopical blood supply of the trachea.

Authors:  J R Salassa; B W Pearson; W S Payne
Journal:  Ann Thorac Surg       Date:  1977-08       Impact factor: 4.330

3.  Resectional operations and long-term results in carcinoma of the esophagus.

Authors:  P Gatzinsky; E Berglin; L Dernevik; I Larsson; G William-Olsson
Journal:  J Thorac Cardiovasc Surg       Date:  1985-01       Impact factor: 5.209

4.  Results of the surgical treatment of carcinoma of the esophagus.

Authors:  B Launois; J L Paul; N J Lygidakis; J P Campion; Y Malledant; D Grossetti; D Delarue
Journal:  Surg Gynecol Obstet       Date:  1983-06

5.  Esophagectomy without thoracotomy.

Authors:  M B Orringer; H Sloan
Journal:  J Thorac Cardiovasc Surg       Date:  1978-11       Impact factor: 5.209

6.  Esophagogastrectomy for carcinoma: current hospital mortality and morbidity rates.

Authors:  F H Ellis; S P Gibb
Journal:  Ann Surg       Date:  1979-12       Impact factor: 12.969

7.  Lymph node metastases in cancer of the thoracic esophagus.

Authors:  Y Sannohe; R Hiratsuka; K Doki
Journal:  Am J Surg       Date:  1981-02       Impact factor: 2.565

8.  En bloc resection for neoplasms of the esophagus and cardia.

Authors:  D B Skinner
Journal:  J Thorac Cardiovasc Surg       Date:  1983-01       Impact factor: 5.209

9.  Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement.

Authors:  H Akiyama; M Tsurumaru; T Kawamura; Y Ono
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

10.  Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy.

Authors:  T Lerut; P De Leyn; W Coosemans; D Van Raemdonck; I Scheys; E LeSaffre
Journal:  Ann Surg       Date:  1992-11       Impact factor: 12.969

View more
  46 in total

1.  Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years.

Authors:  N Ando; S Ozawa; Y Kitagawa; Y Shinozawa; M Kitajima
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma.

Authors:  S Natsugoe; H Yoshinaka; M Shimada; F Sakamoto; T Morinaga; S Nakano; C Kusano; M Baba; S Takao; T Aikou
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

3.  Phase II trial of 5-fluorouracil and low-dose cisplatin in patients with squamous cell carcinoma of the esophagus.

Authors:  H Sekiguchi; S Akiyama; M Fujiwara; H Nakamura; K Kondo; Y Kasai; K Ito; J Sakamoto; H Takagi
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Precise delineation of clinical target volume for crossing-segments thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases.

Authors:  Yuanli Dong; Hui Guan; Wei Huang; Zicheng Zhang; Dongbo Zhao; Yang Liu; Tao Zhou; Baosheng Li
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

5.  [Preoperative evaluation of prognostic factors in esophageal squamous cell cancer].

Authors:  P M Schneider; D Vallböhmer; J Brabender; A H Hölscher
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

Review 6.  Accuracy of endoscopic ultrasound in the diagnosis of distal and celiac axis lymph node metastasis in esophageal cancer: a meta-analysis and systematic review.

Authors:  Srinivas R Puli; Jyotsna B K Reddy; Matthew L Bechtold; Mainor R Antillon; Jamal A Ibdah
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

7.  Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy.

Authors:  Chikara Kunisaki; Hirochika Makino; Ryo Takagawa; Naoto Yamamoto; Yasuhiko Nagano; Syoichi Fujii; Takashi Kosaka; Hidetaka A Ono; Yuichi Otsuka; Hirotoshi Akiyama; Yasushi Ichikawa; Hiroshi Shimada
Journal:  J Gastrointest Surg       Date:  2007-10-20       Impact factor: 3.452

8.  Extranodal spreading of esophageal squamous cell carcinoma: clinicopathological characteristics and prognostic impact.

Authors:  Tadashi Tanabe; Tatsuo Kanda; Shin-Ichi Kosugi; Yoshiyuki Ikeda; Shigeto Makino; Shintaro Komukai; Manabu Ohashi; Tsutomu Suzuki; Katsuyoshi Hatakeyama
Journal:  World J Surg       Date:  2007-09-17       Impact factor: 3.352

9.  Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma.

Authors:  Punit Sharma; Sachin Jain; Sellam Karunanithi; Sujoy Pal; Pramod Kumar Julka; Sanjay Thulkar; Arun Malhotra; Chandrasekhar Bal; Rakesh Kumar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-17       Impact factor: 9.236

10.  Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus.

Authors:  Nasser Altorki; Michael Kent; Cathy Ferrara; Jeffrey Port
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.